A study to explore heart function during first dose administration of fingolimod in patients with relapsing-remitting multiple sclerosis

Update Il y a 4 ans
Reference: EUCTR2012-000653-32

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the incidence of patients with bradycardia (heart rate < 45 beats per min) and bradyarrhythmic ECG events during 6-hour monitoring period as measured by heart rate and second and third-degree AV blocks after treatment initiation of fingolimod 0.5 mg.


Inclusion criteria

  • Conduction abnormalities in patients with relapsing-remitting multiple sclerosis

Links